The University of California, Irvine seeks a Director, Early Phase Clinical Trials & Precision Therapeutics. The incumbent will be responsible for development and growth of UCI’s early phase clinical trials portfolio for both oncology and non-oncology indications, across the UCI Chao Family Comprehensive Cancer Center’s (CFCCC) Stern Center for Cancer Clinical Trials & Research (Stern Center), the UCI Center for Clinical Research (CCR), and the UCI Alpha Stem Cell Clinic (ASCC).
Responsibilities:
Develop and lead a coordinated Phase I program for cooperative group, industry, and institutional/investigator-initiated clinical trials across all therapeutic areas
Oversee, encourage, facilitate, and maximize enrollment on Phase I and Phase II trials across disease sites and various Departments. An important component will be developing a strong working relationship with basic science and clinical department chairs and center directors.
Create, nurture and maintain critical contacts with industry partners
Work with institutional leadership across the three research entities (CFCCC Associate Director for Translational Science, CCR Medical Director, ASCC Medical Director) and the dean’s office (Vice Deans for Research) to promote the translation of scientific discoveries toward the clinic through interactions with the various clinical research units at UCI
With the Department of Pathology and Laboratory Medicine, create and develop the infrastructure to support a regularly held molecular tumor board or equivalent
Ensure sufficient support levels for clinical/translational research including regulatory approval processes, biospecimen collection, and clinical research coordination; in short, all aspects of the clinical/translational research effort
Ensure an efficient infrastructure for formulation, launch, and completion of investigator-initiated early-phase clinical trials
Facilitate early phase clinical trials designed to maximize the development of cutting-edge therapies
Promote rapid progress by the Early Phase Clinical Trials Unit in cancer immunotherapy
Position the Early Phase Clinical Trials Unit to serve as a hub for precision medicine clinical trials by fostering seamless integration of oncology, genomics, computational biology, pathology, interventional and diagnostic radiology, and medical and surgical specialties
Develop innovative cellular therapies, collaborate in trial design, provide medical expertise, provide feedback on the scientific merit of the trials, and identify unmet medical needs and opportunities for pioneering new technologies
Ensure that early phase clinical research efforts reflect the health disparities and needs of the entirety of Orange County (e.g., underserved populations, including Latino and Asian populations)
Coordinate with the Disease-Oriented Teams across UCI Health, which function to facilitate the translation of basic science discoveries through the pipeline towards the clinic and assess the scientific quality of proposed protocols
Represent UCI and the CFCCC in this area for the University of California Cancer Consortium
Qualifications:
· MD, MD/PhD degree or equivalent
· Experience with phase 1 clinical trials in oncology
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
Apply link:
https://recruit.ap.uci.edu/JPF07744